Fig. 1.

Real-world survival outcomes, rwOS (a), rwPFS (b), rwEFS (c), and rwMFS (d), among men with LPC/LAPC identified from claims data following primary treatment. 95% confidence intervals shown in shading around plotted lines. ADT androgen deprivation therapy, CI confidence interval, rwEFS real-world event-free survival, rwMFS real-world metastasis-free survival, rwOS real-world overall survival; rwPFS real-world progression-free survival; EHR electronic health records, LAPC locally advanced prostate cancer, LPC localized prostate cancer, RP radical prostatectomy, RT radiotherapy